RxDoctor Payments Data

John Mattei, MD

Family Medicine · Columbia, SCNPI 1316959687

Payments from drug & device makers

$14,564in general payments, 2019–2025

Across 1,008 payments — averaging $14.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$1K
  • Pfizer$1K
  • AstraZeneca$1K
  • Amgen$801
  • Kowa Pharmaceuticals America, Inc.$731
  • plus $8K from 54 others

What the payments were for

  • Food & beverage$14,46999%
  • Education$961%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk97$1,441
AbbVie(2 entities)135$1,327
Pfizer87$1,264
AstraZeneca70$1,185
Amgen(2 entities)61$801
Kowa Pharmaceuticals America, Inc.74$731
Astellas Pharma US Inc38$658
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC41$631
Boehringer Ingelheim32$557
Abbott30$533
Novartis32$463
Bayer23$443
Azurity Pharmaceuticals, Inc.26$384
Amarin Pharma, Inc.25$357
Merck22$283
Lilly USA, LLC19$267
GSK19$264
Exact Sciences16$249
Otsuka America Pharmaceutical, Inc.11$246
Teva Pharmaceuticals USA, Inc.13$227
Arbor Pharmaceuticals, Inc.14$186
Sumitomo Pharma America, Inc.9$178
Sanofi-aventis U.S. LLC10$154
Johnson & Johnson10$153
Eisai Inc.9$141
Antares Pharma, Inc.7$132
Lundbeck LLC6$126
Biohaven Pharmaceuticals, Inc.7$125
Takeda Pharmaceuticals U.S.A., Inc.9$113
Biohaven Pharmaceutical Holding Company Ltd.5$91
Axsome Therapeutics, Inc.4$83
Upsher-smith Laboratories LLC5$76
Esperion Therapeutics, Inc.4$73
Inari Medical, Inc.2$73
Sunovion Pharmaceuticals Inc.3$58
Shire North American Group Inc3$41
Acerus Pharmaceuticals Corporation3$39
Harmony Biosciences LLC2$32
Ironwood Pharmaceuticals, Inc2$28
Insulet Corporation1$26
Boston Scientific1$22
Promius Pharma LLC1$21
Paratek Pharmaceuticals, Inc.1$18
Halozyme Inc1$17
Bausch Health US, LLC1$17
Xeris Pharmaceuticals, Inc.1$17
Zyla Life Sciences, Inc.1$16
Almatica Pharma LLC1$16
Scynexis, Inc.1$16
E.r. Squibb & Sons, L.L.C.1$15
Dexcom, Inc.1$15
Abiomed1$14
Corcept Therapeutics1$14
Edwards Lifesciences1$14
Endo Pharmaceuticals Inc.1$13
Assertio Therapeutics, Inc.1$13
Therapeuticsmd, Inc.1$13
IBSA Pharma Inc.1$12
Sanofi Pasteur Inc.1$12
Phathom Pharmaceuticals, Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,564 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$398,478
Medicare patients
660
Services billed
33,213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide109$202,771
JardianceEmpagliflozin94$118,760
FarxigaDapagliflozin Propanediol85$104,933
EliquisApixaban103$96,470
MounjaroTirzepatide42$61,395
JanuviaSitagliptin Phosphate31$40,371
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog43$35,037
RybelsusSemaglutide18$27,231
MyrbetriqMirabegron29$25,846
JanumetSitagliptin Phos/Metformin Hcl30$23,534
LinzessLinaclotide20$21,614
Rosuvastatin Calcium553$8,636
Omeprazole426$6,439
SymbicortBudesonide/Formoterol Fumarate17$6,078
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide160$5,839

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,441$230,002127 claims
Boehringer IngelheimJardiance$557$118,76094 claims
AstraZenecaFarxiga, Symbicort$1,185$111,011102 claims
PfizerEliquis$1,264$96,470103 claims
MerckJanuvia, Janumet$283$63,90561 claims
Lilly USA, LLCMounjaro$267$61,39542 claims
Astellas Pharma US IncMyrbetriq$658$25,84629 claims
AbbVieLinzess$1,327$21,61420 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →